J.-S. Park et al. / Tetrahedron Letters 44 (2003) 1611–1614
1613
References
1. For a review, see: (a) Goodman, M.; Ro, S. In Burger’s
Medicinal Chemistry and Drug Discovery, 5th ed.; Wiley:
New York, 1995; Vol. I, pp. 803–861; (b) Creighton, T. E.
Proteins: Structure and Molecular Properties, 2nd ed.;
Freeman: New York, 1993.
2. For example, see: (a) Feigel, M.; Brandmeier, V.; Bremer,
M. Angew. Chem., Int. Ed. Engl. 1989, 28, 486; (b)
Callahan, J. F.; Bean, J. W.; Burgess, J. L.; Eggleston, D.
S.; Hwang, S. M.; Kopple, K. D.; Koster, P. F.; Nichols,
A.; Peishoff, C. E.; Samanen, J. M.; Vasko, J. A.; Wong,
A.; Huffman, W. F. J. Med. Chem. 1992, 35, 3970; (c)
Kemp, D. S.; Carter, J. S. J. Org. Chem. 1989, 54, 109; (d)
Smith, A. B.; Keenan, T. P.; Holcomb, R. C.; Sprengeler,
P. A.; Guzman, M. C.; Wood, J. L.; Carroll, P. J.;
Hirschmann, R. J. Am. Chem. Soc. 1992, 114, 10672; (e)
Gardner, B.; Nakanishi, H.; Kahn, M. Tetrahedron 1993,
49, 3433.
3. Kim, B. M.; Shaw, A. W.; Graham, S. L.; deSolms, J. S.;
Ciccarone, T. M. US Patent 5,817,678, Oct. 6, 1998.
4. (a) Angenot, L.; Dideberg, O.; Dupont, L. Tetrahedron
Lett. 1975, 16, 1357–1358; (b) Benson, W.; Winterfeldt, E.
Heterocycles 1981, 15, 935–941; (c) Danieli, B.; Lesma, G.;
Mauro, M.; Palmisano, G. In Chemoenzymatic Approach
to some Indole Alkaloids: Heterocycles in Bioorganic Chem-
istry; Bergman, J.; Van der Plas, H. C.; Somonyi, M., Eds.;
1991; pp. 28–53; (d) Danieli, B.; Lesma, G.; Passarella, D.;
Riva, S. In Advances in the Use of Synthons in Organic
Chemistry; Dondoni, A., Ed.; Chiral Synthons via
Enzyme-Mediated Asymmetrization of Meso-Com-
pounds; 1993; Vol. 1, pp. 143–219.
Scheme 4. a) Ac2O, pyr; b) LiOH, THF–water; c) MeNH2,
EDC, HOBt, DMF; d) TFA, CH2Cl2.
The absolute stereochemistry of the product (+)-cis-4
was determined by comparison of optical rotation of
(3S)-N-t-butyloxycarbonyl-3-hydroxymethyl-1-pipe-
ridine derived from (+)-cis-4 with literature data {[h]365
+60.7 (c 1, EtOH)}.7b,14 This result revealed that half-
acid (+)-cis-4 resolved with (−)-PEA is equipped with a
(3S,5R) absolute configuration as shown in Scheme 3.
Optically active half-acid (+)-cis-4 was converted into
b,g%-diamino acid derivative 6 through Curtius-type
rearrangement.15 Treatment of (+)-cis-4 with
diphenylphosphoryl azide (DPPA) and Et3N in anhy-
drous benzene provided isocyanate intermediate, which
was quenched with 2-(trimethylsilyl)ethanol to give
orthogonally protected diamino acid 6 (Scheme 3).
For preliminary conformational analysis of compounds
incorporating this unnatural cyclic amino acid unit, a
pseudopeptide derivative 9 was prepared from free
amine 7 through acetylation of the amine, hydrolysis of
the methyl ester, coupling of the corresponding free
carboxylic acid with methylamine followed by deprotec-
tion of the N-Boc group as shown in Scheme 4. Con-
formational search through molecular mechanics of the
resulting compound 9 followed by optimization using
ab initio calculation (HF/3-21G*, 41 conformations)
5. For some recent examples, see: (a) Schneider, J. P.; Kelly,
J. W. J. Am. Chem. Soc. 1995, 117, 2533; (b) Gardner, R.
R.; Liang, G. B.; Gellman, S. H. J. Am. Chem. Soc. 1995,
117, 3280; (c) Nowick, J. S.; Mahrus, S.; Smith, E. M.;
Ziller, J. W. J. Am. Chem. Soc. 1996, 118, 1066; (d) Das,
C.; Raghothama, S.; Balaram, P. J. Am. Chem. Soc. 1998,
120, 5812; (e) Nowick, J. S. Acc. Chem. Res. 1999, 32, 287;
(f) Nowick, J. S.; Chung, D. M.; Maitra, K.; Maitra, S.;
Stigers, K. D.; Sun, Y. J. Am. Chem. Soc. 2000, 122, 7654;
(g) Fisk, J. D.; Powell, D. R.; Gellman, S. H. J. Am. Chem.
Soc. 2000, 122, 5443; (h) Nowick, J. S.; Cary, J. M.; Tsai,
J. H. J. Am. Chem. Soc. 2001, 123, 5176.
6. For representative examples, see: (a) Freidinger, R. M.;
Veber, D. F.; Perlow, D. S.; Brooks, J. R.; Saperstein, R.
Science, 1980, 210, 656; (b) Kemp, D. S.; Sun, E. T.
Tetrahedron Lett. 1982, 23, 3759; (c) Nagai, U.; Sato, K.
Tetrahedron Lett. 1985, 26, 647; (d) Kahn, M.; Wilke, S.;
Chen, B.; Fujita, K. J. Am. Chem. Soc. 1988, 110, 1638;
(e) Lombart, H.-G.; Lubell, W. D. J. Org. Chem. 1996, 61,
9437; (f) Slomczynsks, U.; Chalmers, D. K.; Cornille, F.;
Smythe, M. L.; Beusen, D. D.; Moeller, K. D.; Marshall,
G. R. J. Org. Chem. 1996, 61, 1198; (g) Jean, F.; Buisine,
E.; Melnyk, O.; Drobecq, H.; Odaert, B.; Hugues, M.;
Lippens, G.; Tartar, A. J. Am. Chem. Soc. 1998, 120, 6076;
(h) Jones, I. G.; Jones, W.; North, M. J. Org, Chem. 1998,
63, 1505; (i) Gennari, C.; Mielgo, A.; Potenza, D.; Scolas-
tico, C.; Piarulli, U.; Manzoni, L. Eur. J. Org. Chem. 1999,
379; (j) Gardner, R. R.; Liang, G.-B.; Gellman, S. H. J.
Am. Chem. Soc. 1999, 121, 1806; (k) Jime´nez, A. I.;
Cativiela, C.; Marraud, M. Tetrahedron Lett. 2000, 41,
5353.
1
and H NMR studies in water (DQF-COSY, ROESY,
and temperature variation experiment) indicate the
extended b-strand structure A as depicted in Scheme 4.
In conclusion, we have developed an efficient method
for the preparation of a conformationally constrained,
unnatural b,g%-diamino acid derivative 6. We are cur-
rently investigating the possibility of constructing a
combinatorial library toward various enzyme inhibitors
including serine and aspartyl proteases from this inter-
esting unnatural amino acid scaffold and the result will
be reported in due course.
Acknowledgements
We thank the Center for Molecular Catalysis at Seoul
National University through KOSEF and LGLS for
generous financial support for this work. J.S.P. and
C.E.Y. acknowledge the financial support in the form
of BK21 fellowships.